-
Mashup Score: 0
Background Sacubitril/valsartan and angiotensin-converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) therapies were reported to affect glycaemic control and the development of diabetes mellitus (DM), but the findings are inconsistent. We examined the evidence for the effects of sacubitril/valsartan and ACEI/ARB in DM by conducting a meta-analysis. Methods The Cochrane Central…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status - 1 year(s) ago
Dysglycaemia is a metabolic state characterised by an HbA1c level above the normal range and includes anyone with slightly elevated glucose concentrations, impaired fasting glucose, impaired glucose tolerance, or diabetes. Since the term was first coined in 1996,1 analyses of many prospective studies have clearly shown a progressive relationship between the degree of dysglycaemia and…
Categories: Endocrinology, Latest HeadlinesTweet-
Hertzel C Gerstein & Naveed Sattar comment on: Reduction in heart failure outcomes with #SGLT2 inhibitors irrespective of #glycaemic status https://t.co/Bq1ZsB8yT8 #HeartFailure #diabetes
-
-
Mashup Score: 0Glycaemic management in diabetes: old and new approaches - 1 year(s) ago
HbA1c is the most used parameter to assess glycaemic control. However, evidence suggests that the concept of hyperglycaemia has profoundly changed and that different facets of hyperglycaemia must be considered. A modern approach to glycaemic control should focus not only on reaching and maintaining optimal HbA1c concentrations as early as possible, but to also do so by reducing postprandial…
Categories: Endocrinology, Latest HeadlinesTweet-
#Glycaemic management in #diabetes: old and new approaches https://t.co/fuONBpPm9F #T1D #T2D #IDF2022
-
-
Mashup Score: 2Glycaemic management in diabetes: old and new approaches - 1 year(s) ago
HbA1c is the most used parameter to assess glycaemic control. However, evidence suggests that the concept of hyperglycaemia has profoundly changed and that different facets of hyperglycaemia must be considered. A modern approach to glycaemic control should focus not only on reaching and maintaining optimal HbA1c concentrations as early as possible, but to also do so by reducing postprandial…
Categories: Endocrinology, Latest HeadlinesTweet-
#Glycaemic management in #diabetes: old and new approaches https://t.co/fuONBq6Xyf #T1D #T2D
-
-
Mashup Score: 0
In patients with heart failure with mildly reduced or preserved ejection fraction, oral dapagliflozin improved heart failure outcomes to a similar extent in three glycaemia subgroups: normoglycaemia, prediabetes, and type 2 diabetes. Moreover, the heart failure benefits of dapagliflozin seem to be consistent across a continuous glycaemic range.
Categories: Endocrinology, Latest HeadlinesTweet-
Efficacy and safety of #dapagliflozin in patients with #heartfailure with mildly reduced or preserved ejection fraction by baseline #glycaemic status (#DELIVER): a subgroup analysis from a ... multicentre, double-blind, randomised, placebo-controlled trial https://t.co/YDLCsqRz3s
-
-
Mashup Score: 0Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status - 1 year(s) ago
Dysglycaemia is a metabolic state characterised by an HbA1c level above the normal range and includes anyone with slightly elevated glucose concentrations, impaired fasting glucose, impaired glucose tolerance, or diabetes. Since the term was first coined in 1996,1 analyses of many prospective studies have clearly shown a progressive relationship between the degree of dysglycaemia and…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read the Linked Comment: Reduction in #heartfailure outcomes with #SGLT2 inhibitors irrespective of #glycaemic status https://t.co/Bq1ZsAQpF0 #diabetes
-
-
Mashup Score: 0Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status - 1 year(s) ago
Dysglycaemia is a metabolic state characterised by an HbA1c level above the normal range and includes anyone with slightly elevated glucose concentrations, impaired fasting glucose, impaired glucose tolerance, or diabetes. Since the term was first coined in 1996,1 analyses of many prospective studies have clearly shown a progressive relationship between the degree of dysglycaemia and…
Categories: Endocrinology, Latest HeadlinesTweet-
Hertzel C Gerstein & Naveed Sattar comment on: Reduction in heart failure outcomes with #SGLT2 inhibitors irrespective of #glycaemic status https://t.co/Bq1ZsB813A #diabetes #heartfailure
-
-
Mashup Score: 0Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status - 1 year(s) ago
Dysglycaemia is a metabolic state characterised by an HbA1c level above the normal range and includes anyone with slightly elevated glucose concentrations, impaired fasting glucose, impaired glucose tolerance, or diabetes. Since the term was first coined in 1996,1 analyses of many prospective studies have clearly shown a progressive relationship between the degree of dysglycaemia and…
Categories: Endocrinology, Latest HeadlinesTweet-
Hertzel C Gerstein & Naveed Sattar comment on: Reduction in #heartfailure outcomes with #SGLT2 inhibitors irrespective of #glycaemic status https://t.co/Bq1ZsB8yT8 #dapagliflozin
-
-
Mashup Score: 0Glycaemic management in diabetes: old and new approaches - 1 year(s) ago
HbA1c is the most used parameter to assess glycaemic control. However, evidence suggests that the concept of hyperglycaemia has profoundly changed and that different facets of hyperglycaemia must be considered. A modern approach to glycaemic control should focus not only on reaching and maintaining optimal HbA1c concentrations as early as possible, but to also do so by reducing postprandial…
Categories: Endocrinology, Latest HeadlinesTweet-
#Glycaemic management in #diabetes: old and new approaches https://t.co/fuONBpPm9F #T1D #T2D #WorldDiabetesDay2022 #EducationToProtect
-
-
Mashup Score: 0Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status - 1 year(s) ago
Dysglycaemia is a metabolic state characterised by an HbA1c level above the normal range and includes anyone with slightly elevated glucose concentrations, impaired fasting glucose, impaired glucose tolerance, or diabetes. Since the term was first coined in 1996,1 analyses of many prospective studies have clearly shown a progressive relationship between the degree of dysglycaemia and…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read the Linked Comment: Reduction in heart failure outcomes with #SGLT2 inhibitors irrespective of #glycaemic status https://t.co/Bq1ZsB8yT8 #diabetes #HeartFailure
-
#Sacubitril/#valsartan found effective in #diabetes prevention via meta-analysis of #RCT https://t.co/ge4I4FN5SU #SacVal =>🔼#glycaemic control &🔽new-onset #diabetesmellitus, especially in #heartfailure Read this and other #HFpEF collection articles - https://t.co/EDhzbGSZFP https://t.co/l28zEOjxBL